bz371b
Peptideexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 30, 2022 (NCT05384379)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Nitric-oxide synthase, brainACTIVATOR
NOS1 activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05384379 | Early Phase 1 (Phase 1) | Nov 30, 2022 | Biozeus Biopharmaceutical S.A., University of Sao Paulo |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Biozeus Biopharmaceutical S.A. | For profit | 1 | 1 | 1 | 2022 |
| University of Sao Paulo | Academic/Hospital | 1 | 0 | 1 | 2022 |
2 organizations
Page 1 / 1